Exhibit 99.1
logo.jpg
Protolabs Reports Financial Results for the Third Quarter of 2026
Record Quarterly Revenue of $154.3 Million, a 14.0% Increase Year-Over-Year
GAAP Earnings Per Share of $0.48, up 61% YoY; Non-GAAP Earnings Per Share of $0.63, up 33% YoY
Raising Full Year 2026 Revenue Growth Guidance from 8% - 10% to 10% - 11%
MINNEAPOLIS – October 29, 2026 – Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the third quarter ended September 30, 2026.

Third Quarter 2026 Financial Highlights:
•Revenue was a record $154.3 million, a 14.0% increase over the third quarter of 2025.
◦Total revenue per customer contact increased 16.6% year-over-year.
◦CNC machining revenue grew 16.4% year-over-year.
◦Injection molding revenue grew 12.5% year-over-year.
◦3D printing revenue grew 11.4% year-over-year.
•GAAP operating margin was 9.4%, up from 6.5% in the third quarter of 2025. Non-GAAP operating margin was 11.9%, up from 10.0% in the third quarter of 2025.
•GAAP net income was $0.48 per diluted share, compared to $0.30 per diluted share in the third quarter of 2025. Non-GAAP net income was $0.63 per diluted share, compared to $0.47 per diluted share in the third quarter of 2025.

Note: See “Non-GAAP Financial Measures” below.

"Protolabs delivered another record quarter, with double-digit revenue growth for the fourth consecutive quarter," said Suresh Krishna, President and Chief Executive Officer. "Our momentum reflects strong execution and growing demand from industries that value speed, quality, and manufacturing agility. As reindustrialization, advanced hardware innovation, and the need for resilient supply chains reshape manufacturing, our digital model enables customers to move quickly from idea to production — positioning us to deliver sustained profitable growth and long-term shareholder value."

Additional Third Quarter 2026 Financial Highlights:
•GAAP net income was $11.8 million, or 7.6% of revenue, up 63.0% compared to $7.2 million, or 5.3% of revenue in the third quarter of 2025.
•Adjusted EBITDA was $26.2 million, or 17.0% of revenue, up 23.8% compared to $21.1 million, or 15.6% of revenue, in the third quarter of 2025. See “Non-GAAP Financial Measures” below.
•Cash generated from operations was $22.8 million.
•Cash and investments balance was $175.0 million as of September 30, 2026.

"We delivered another quarter of strong financial performance, with broad-based revenue growth, meaningful operating leverage, and continued earnings growth," said Dan Schumacher, Chief Financial Officer. "We remain focused on balancing investments in our strategic priorities with disciplined cost management, while generating strong cash flow and positioning the business for sustained profitable growth."

Financial Guidance and Outlook:

•For full year 2026, Protolabs is raising its guidance and now expects revenue growth between 10% and 11%.
•For the fourth quarter of 2026, the Company expects revenue between $143.0 million and $151.0 million.



•For the fourth quarter of 2026, the Company expects GAAP diluted net income per share between $0.28 and $0.36, and non-GAAP diluted net income per share between $0.46 and $0.54. See "Non-GAAP Financial Measures" below.

Non-GAAP Financial Measures
The Company has included non-GAAP revenue growth by region and by product line that excludes the impact of changes in foreign currency exchange rates (collectively, “non-GAAP revenue growth”). Management believes these metrics, when viewed in conjunction with the comparable metrics calculated in accordance with generally accepted accounting principles in the United States ("GAAP"), are useful in evaluating the underlying business trends and ongoing operating performance of the Company.
The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs (“Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense, amortization expense and trade refunds and charges, net ("non-GAAP gross margin"), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs (“non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP net income and non-GAAP net income per share, in each case, adjusted for stock-based compensation expense, amortization expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs (“non-GAAP net income” and "non-GAAP net income per share", respectively), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP net income per share, non-GAAP gross margin, non-GAAP operating margin, non-GAAP revenue growth by region and by product line, EBITDA, EBITDA margin, Adjusted EBITDA and Adjusted EBITDA margin to the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends, provide useful measures for period-to-period comparisons of the Company’s business, and in determining executive and senior management incentive compensation. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as the Company's management and board of directors. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in the Company's condensed consolidated financial statements and are subject to inherent limitations. Investors should review the reconciliations of non-GAAP financial measures to the comparable GAAP financial measures that are included in this press release.
Conference Call
The Company has scheduled a conference call to discuss its third quarter 2026 financial results and fourth quarter 2026 outlook today, October 29, 2026, at 8:30 a.m. EDT. To access the call in the U.S., please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/ec8fzrj2/. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.



About Protolabs
Protolabs is the world’s fastest manufacturing service enabling companies across every industry to streamline production of quality parts throughout the entire product life cycle. From custom prototyping to end-use production, we support product developers, engineers, and supply chain teams along every phase of their manufacturing journey. Get started now at protolabs.com.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

Source: Proto Labs, Inc.

Investor Relations Contacts
Protolabs
Ryan Johnsrud, 612-225-4873
Sr. Manager – Investor Relations and Corporate Development
ryan.johnsrud@protolabs.com

Gateway Group, Inc.
949-574-3860
PRLB@gateway-grp.com
Media Contact
Protolabs
Brent Renneke, 763-479-7704
Corporate Communications Manager
brent.renneke@protolabs.com



Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
September 30,
2026
December 31,
2025
(Unaudited)
Assets
Current assets
Cash and cash equivalents$133,780 $110,826 
Short-term marketable securities17,366 17,297 
Accounts receivable, net99,256 78,962 
Inventory16,538 14,401 
Prepaid expenses and other current assets11,844 9,590 
Income taxes receivable744 2,465 
Total current assets279,528 233,541 
Property and equipment, net206,932 215,261 
Goodwill273,991 273,991 
Other intangible assets, net15,663 18,612 
Long-term marketable securities23,903 14,308 
Operating lease assets3,130 2,836 
Finance lease assets— 424 
Other long-term assets4,874 4,442 
Total assets$808,021 $763,415 
Liabilities and shareholders' equity
Current liabilities
Accounts payable$18,991 $15,104 
Accrued compensation24,632 23,674 
Accrued liabilities and other31,755 26,783 
Current operating lease liabilities1,239 1,155 
Current finance lease liabilities— 286 
Total current liabilities76,617 67,002 
Long-term operating lease liabilities2,664 1,606 
Long-term deferred tax liabilities22,269 16,598 
Other long-term liabilities4,667 4,277 
Shareholders' equity701,804 673,932 
Total liabilities and shareholders' equity$808,021 $763,415 



Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Revenue
Injection Molding$53,730 $47,770 $158,423 $143,908 
CNC Machining73,359 63,043 206,964 177,831 
3D Printing22,364 20,082 63,496 61,491 
Sheet Metal4,063 4,262 12,876 12,776 
Other Revenue802 209 1,236 628 
Total revenue154,318 135,366 442,995 396,634 
Cost of revenue85,655 74,073 241,398 219,869 
Gross profit68,663 61,293 201,597 176,765 
Operating expenses
Marketing and sales24,528 24,574 74,990 73,054 
Research and development11,019 10,705 32,350 32,487 
General and administrative18,241 17,163 54,903 52,763 
Restructuring and transformation costs434 — 2,779 — 
Costs related to exit and disposal activities— 41 937 151 
Total operating expenses54,222 52,483 165,959 158,455 
Income from operations14,441 8,810 35,638 18,310 
Other income, net1,766 1,441 4,489 4,600 
Income before income taxes16,207 10,251 40,127 22,910 
Provision for income taxes4,445 3,035 11,102 7,668 
Net income$11,762 $7,216 $29,025 $15,242 
Net income per share:
Basic$0.49 $0.30 $1.21 $0.64 
Diluted$0.48 $0.30 $1.19 $0.63 
Shares used to compute net income per share:
Basic24,024,03123,889,15723,943,65623,974,054
Diluted24,438,80024,191,03924,398,40924,249,669



Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine Months Ended
September 30,
20262025
Operating activities
Net income$29,025 $15,242 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization24,269 25,693 
Stock-based compensation expense10,658 11,928 
Deferred taxes5,563 2,355 
Interest on finance lease obligations5 16 
Loss on impairment of equipment186 — 
Impairments related to exit and closure of facilities937 448 
Gain on disposal of property and equipment(150)16 
Other(172)(179)
Changes in operating assets and liabilities(14,575)2,355 
Net cash provided by operating activities55,746 57,874 
Investing activities
Purchases of property, equipment and other capital assets(15,539)(6,792)
Proceeds from sales of property, equipment and other capital assets1,279 811 
Purchases of marketable securities(25,507)(13,553)
Proceeds from maturities of marketable securities15,475 11,730 
Net cash used in investing activities(24,292)(7,804)
Financing activities
Proceeds from issuance of common stock from equity plans8,011 4,195 
Purchases of shares withheld for tax obligations(6,083)(3,119)
Repurchases of common stock(10,038)(36,732)
Principal repayments of finance lease obligations(187)(231)
Net cash used in financing activities(8,297)(35,887)
Effect of exchange rate changes on cash and cash equivalents(203)989 
Net increase in cash and cash equivalents22,954 15,172 
Cash and cash equivalents, beginning of period110,826 89,071 
Cash and cash equivalents, end of period$133,780 $104,243 



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income and Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs
GAAP net income$11,762 $7,216 $29,025 $15,242 
Add back:
Stock-based compensation expense3,351 3,677 10,658 11,928 
Amortization expense902 935 2,720 2,770 
Unrealized loss (gain) on foreign currency129 (2)266 (316)
Trade refunds and charges, net(709)— (1,036)— 
Restructuring and transformation costs434 — 2,779 — 
Costs related to exit and disposal activities— 41 937 151 
CEO transition costs— 14 — 1,376 
Total adjustments 1
4,107 4,665 16,324 15,909 
Income tax benefits on adjustments 2
(531)(500)(2,228)(1,700)
Non-GAAP net income$15,338 $11,381 $43,121 $29,451 
Non-GAAP net income per share:
Basic$0.64 $0.48 $1.80 $1.23 
Diluted$0.63 $0.47 $1.77 $1.21 
Shares used to compute non-GAAP net income per share:
Basic24,024,03123,889,15723,943,65623,974,054
Diluted24,438,80024,191,03924,398,40924,249,669
1Stock-based compensation expense, amortization expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs were included in the following GAAP consolidated statement of operations categories:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Cost of revenue$85 $781 $1,370 $2,350 
Marketing and sales798 837 2,322 2,423 
Research and development629 764 1,698 2,124 
General and administrative2,032 2,244 6,952 9,177 
Restructuring and transformation costs434 — 2,779 — 
Costs related to exit and disposal activities— 41 937 151 
Total operating expenses3,893 3,886 14,688 13,875 
Other income, net129 (2)266 (316)
Total adjustments$4,107 $4,665 $16,324 $15,909 
2For the three and nine months ended September 30, 2026 and 2025, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the respective period.



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Revenue$154,318 $135,366 $442,995 $396,634 
Gross profit68,663 61,293 201,597 176,765 
GAAP gross margin44.5%45.3%45.5%44.6%
Add back:
Stock-based compensation expense451 439 1,379 1,323 
Amortization expense343 342 1,027 1,027 
Trade refunds and charges, net(709)— (1,036)— 
Total adjustments85 781 1,370 2,350 
Non-GAAP gross profit$68,748 $62,074 $202,967 $179,115 
Non-GAAP gross margin44.5%45.9%45.8%45.2%



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Revenue$154,318 $135,366 $442,995 $396,634 
Income from operations14,441 8,810 35,638 18,310 
GAAP operating margin9.4%6.5%8.0%4.6%
Add back:
Stock-based compensation expense3,351 3,677 10,658 11,928 
Amortization expense902 935 2,720 2,770 
Trade refunds and charges, net(709)— (1,036)— 
Restructuring and transformation costs434 — 2,779 — 
Costs related to exit and disposal activities— 41 937 151 
CEO transition costs— 14 — 1,376 
Total adjustments3,978 4,667 16,058 16,225 
Non-GAAP income from operations$18,419 $13,477 $51,696 $34,535 
Non-GAAP operating margin11.9%10.0%11.7%8.7%



Proto Labs, Inc.
Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Revenue$154,318 $135,366 $442,995 $396,634 
GAAP net income11,762 7,216 29,025 15,242 
GAAP net income margin7.6%5.3%6.6%3.8%
Add back:
Amortization expense$902 $935 $2,720 $2,770 
Depreciation expense7,206 7,494 21,549 22,923 
Interest income, net(1,355)(1,281)(3,939)(3,532)
Provision for income taxes4,445 3,035 11,102 7,668 
EBITDA22,960 17,399 60,457 45,071 
EBITDA margin14.9%12.9%13.6%11.4%
Add back:
Stock-based compensation expense3,351 3,677 10,658 11,928 
Unrealized loss (gain) on foreign currency129 (2)266 (316)
Trade refunds and charges, net(709)— (1,036)— 
Restructuring and transformation costs434 — 2,779 — 
Costs related to exit and disposal activities— 41 937 151 
CEO transition costs— 14 — 1,376 
Total adjustments3,205 3,730 13,604 13,139 
Adjusted EBITDA$26,165 $21,129 $74,061 $58,210 
Adjusted EBITDA margin17.0%15.6%16.7%14.7%



Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Region
(In thousands)
(Unaudited)
Three Months Ended
September 30, 2026
Three Months Ended
September 30, 2025
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAPGAAP
Revenues
United States$125,412 $— $125,412 $109,361 14.7%14.7%
Europe28,906 267 29,173 26,005 11.212.2
Total revenue$154,318 $267 $154,585 $135,366 14.0%14.2%
Nine Months Ended
September 30, 2026
Nine Months Ended
September 30, 2025
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAPGAAP
Revenues
United States$360,298 $— $360,298 $320,340 12.5%12.5%
Europe82,697 (2,337)80,360 76,294 8.45.3
Total revenue$442,995 $(2,337)$440,658 $396,634 11.7%11.1%

1Revenue for the three and nine months ended September 30, 2026 has been recalculated using 2025 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2025 to GAAP revenue for the three and nine months ended September 30, 2026.
3This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2025 to non-GAAP revenue for the three and nine months ended September 30, 2026 (as recalculated using the foreign currency exchange rates in effect during the three and nine months ended September 30, 2025) in order to provide a constant-currency comparison.



Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Product Line
(In thousands)
(Unaudited)
Three Months Ended
September 30, 2026
Three Months Ended
September 30, 2025
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAPGAAP
Revenues
Injection Molding$53,730 $46 $53,776 $47,770 12.5%12.6%
CNC Machining73,359 184 73,543 63,043 16.4 16.7 
3D Printing22,364 29 22,393 20,082 11.4 11.5 
Sheet Metal4,063 2 4,065 4,262 (4.7)(4.6)
Other Revenue802 6 808 209 283.7 286.6 
Total revenue$154,318 $267 $154,585 $135,366 14.0%14.2%
Nine Months Ended
September 30, 2026
Nine Months Ended
September 30, 2025
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAPGAAP
Revenues
Injection Molding$158,423 $(674)$157,749 $143,908 10.1%9.6%
CNC Machining206,964 (1,248)205,716 177,831 16.4 15.7 
3D Printing63,496 (369)63,127 61,491 3.3 2.7 
Sheet Metal12,876 (48)12,828 12,776 0.8 0.4 
Other Revenue1,236 2 1,238 628 96.8 97.1 
Total revenue$442,995 $(2,337)$440,658 $396,634 11.7%11.1%

1Revenue for the three and nine months ended September 30, 2026 has been recalculated using 2025 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2025 to GAAP revenue for the three and nine months ended September 30, 2026.
3This column presents the percentage change from GAAP revenue for the three and nine months ended September 30, 2025 to non-GAAP revenue for the three and nine months ended September 30, 2026 (as recalculated using the foreign currency exchange rates in effect during the three and nine months ended September 30, 2025) in order to provide a constant-currency comparison.



Proto Labs, Inc.
Customer Contact Information
(In thousands, except customer contacts and per customer contact amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Revenue$154,318 $135,366 $442,995 $396,634 
Customer contacts20,77721,25240,12941,873
Revenue per customer contact1
$7,427 $6,370 $11,039 $9,472 

1Revenue per customer contact is calculated using the revenue recognized during the respective period divided by the actual number of customer contacts served during the same period. Customer contacts are product developers, engineers, procurement and supply chain professionals and other individuals who place an order, and that order is shipped and invoiced during the period. The Company believes revenue per customer contact is useful to investors in evaluating the underlying business trends and ongoing operating performance of the Company.
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Guidance
(Unaudited)

Q4 2026 Outlook
LowHigh
GAAP diluted net income per share$0.28 $0.36 
Add back:
Stock-based compensation expense0.15 0.15 
Amortization expense0.03 0.03 
Total adjustments0.18 0.18 
Non-GAAP diluted net income per share$0.46 $0.54